(2003) Maximizing benefits and minimizing risks in palliative care research that involves patients near the end of life. Journal of Pain and Symptom Management, 25 (4), pp. S53-S62.Fine P. Maximizing benefits and minimizing risks in palliative care research that involves patients near the end...
4. Do one thing you dream of doing that others disdain or ridicule. Bonnie Ware worked in palliative care, spending time with patients who had only a few months to live. Their most common regret was, “I wish I’d had the courage to live a life true to myself, not the life others...
- 《Journal of Emergency Nursing Jen Official Publication of the Emergency Department Nurses Association》 被引量: 2发表: 2016年 In the Belgian chateau: Rare "synergism" between euthanasia and palliative care Along with several coauthors, Distelmans wrote "Palliative sedation: Why we should be ...
Furthermore, she stressed a need to correct misconceptions of palliative care as exclusively entailing pre-hospice care, highlighting benefit in all patients regardless of disease stage. Rone iterated that addressing psychosocial needs for patients varies depending on a patient’s circumstances. Rone ...
Issues and challenges in palliative care for children with cancer Although the majority of children with cancer are cured of their illness, the children who die from their disease or complications require special care at ... DL Friedman,JM Hilden,K Powaski - 《Current Pain & Headache Reports》...
This multicenter randomized clinical trial evaluates whether provision of a palliative care educational video/booklet at treatment initiation could
Dr. Jessica Pyhtila is a Clinical Pharmacy Specialist based in Baltimore, Maryland with practice sites in inpatient palliative care and outpatient primary care at the Department of Veteran Affairs.Read more Sources World Health Organization. “Alcohol”>Alcohol.” Accessed August 23, 2023. ...
RD Dennison - 《Journal of Continuing Education in Nursing》 被引量: 58发表: 2007年 Neuropsychiatric complications of commonly used palliative care drugs. If unrecognised, these effects can generate considerable distress and unnecessary harm to patients. We aim to highlight some of the adverse neurop...
Busulfan is an antineoplastic agent with cell-cycle nonspecific alkylating action4 and is used as a palliative treatment for chronic myelogenous leukemia. Busulfan is also used for the treatment of polycythemia vera, myelofibrosis, primary thrombocythemia, and as conditioning regimens to prepare patients...
Patients receiving palliative care only were excluded from the data set. The different regimens used to treat these patients were classified as low, intermediate, or high intensity as indicated in eTable 1 in the Supplement.Outcome Death within 1 year from initial therapy was the outcome of ...